Moneycontrol PRO

Cadila: a formidable play in Covid times and beyond

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

September 25, 2020 / 05:47 PM IST
Cadila: a formidable play in Covid times and beyond

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Cadila’s Covid vaccine undergoing phase II trials; seeking a range of options - Strong foray into injectables, biologics – a key watch - R&D expense of 7-8 percent of sales heavily allocated for biosimilars - Growing India presence provides stable cash flow visibility Cadila Healthcare (CMP: Rs 376, Market cap: Rs 38,497 crore), known to be one of India’s formidable plays on Covid solutions is a worth a watch, even after the fading of the hydroxychloroquine (HCQS) opportunity. HCQS, which was touted as an early solution...

  • PRO Panorama

    Moneycontrol Pro Panorama | It all starts and ends in the bond market

    Mar 31, 2023 / 03:20 PM IST

    In today’s edition of Moneycontrol Pro Panorama: India's growing gaming market needs better policies, the only solution to the b...

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender: Between the Fed and a hard place

    Mar 11, 2023 / 11:38 AM IST

    The Fed is caught between combating inflation and worries over a financial mishap

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers